Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Articles by Anita M. Hennige
Total Records ( 1 ) for Anita M. Hennige
  Rizwana Sanaullah Waraich , Cora Weigert , Hubert Kalbacher , Anita M. Hennige , Stefan Z. Lutz , Hans-Ulrich Haring , Erwin D. Schleicher , Wolfgang Voelter and Rainer Lehmann
  The activation of the protein kinase C (PKC) family of serine/threonine kinases contributes to the modulation of insulin signaling, and the PKC-dependent phosphorylation of insulin receptor substrate (IRS)-1 has been implicated in the development of insulin resistance. Here we demonstrate Ser357 of rat IRS-1 as a novel PKC-δ-dependent phosphorylation site in skeletal muscle cells upon stimulation with insulin and phorbol ester using Ser(P)357 antibodies and active and kinase dead mutants of PKC-δ. Phosphorylation of this site was simulated using IRS-1 Glu357 and shown to reduce insulin-induced tyrosine phosphorylation of IRS-1, to decrease activation of Akt, and to subsequently diminish phosphorylation of glycogen synthase kinase-3. When the phosphorylation was prevented by mutation of Ser357 to alanine, these effects of insulin were enhanced. When the adjacent Ser358, present in mouse and rat IRS-1, was mutated to alanine, which is homologous to the human sequence, the insulin-induced phosphorylation of glycogen synthase kinase-3 or tyrosine phosphorylation of IRS-1 was not increased. Moreover, both active PKC-δ and phosphorylation of Ser357 were shown to be necessary for the attenuation of insulin-stimulated Akt phosphorylation. The phosphorylation of Ser357 could lead to increased association of PKC-δ to IRS-1 upon insulin stimulation, which was demonstrated with IRS-1 Glu357. Together, these data suggest that phosphorylation of Ser357 mediates at least in part the adverse effects of PKC-δ activation on insulin action.
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility